1 Institute for Pharmacology and Toxicology, Helga & Erich Kellerhals Laboratories for Novel Therapeutics, Center for Pharmacogenetics and Pharmacogenomics, Paracelsus Medical University, Strubergasse 21, 5020 Salzburg, Austria.
2 European Medicines Agency, 7 Westferry Circus, Canary Wharf, London E14 4HB, UK.
3 Mayo Clinic Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota 55995, USA.
4 Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, 132 South 10th Street, Philadelphia 19107, USA.
Recent policy developments in the European Union and elsewhere aim to tackle some of the key issues responsible for the limited adoption of personalized medicine approaches so far.